| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 69 | 2024 | 322 | 28.380 |
Why?
|
| Endoscopy | 45 | 2024 | 353 | 14.140 |
Why?
|
| Coronary Artery Bypass | 46 | 2024 | 239 | 12.450 |
Why?
|
| Coronary Artery Disease | 30 | 2024 | 373 | 12.210 |
Why?
|
| Cardiac Surgical Procedures | 25 | 2024 | 482 | 8.820 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 17 | 2024 | 40 | 7.930 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2025 | 182 | 5.090 |
Why?
|
| Robotics | 14 | 2022 | 270 | 5.030 |
Why?
|
| Mammary Arteries | 13 | 2024 | 34 | 5.010 |
Why?
|
| Percutaneous Coronary Intervention | 6 | 2022 | 69 | 3.870 |
Why?
|
| Minimally Invasive Surgical Procedures | 22 | 2024 | 259 | 3.830 |
Why?
|
| Aortic Valve | 10 | 2024 | 251 | 3.750 |
Why?
|
| Coronary Vessels | 9 | 2024 | 194 | 3.630 |
Why?
|
| Mitral Valve Insufficiency | 8 | 2024 | 198 | 3.020 |
Why?
|
| Mitral Valve | 12 | 2024 | 267 | 2.990 |
Why?
|
| Treatment Outcome | 44 | 2025 | 8386 | 2.810 |
Why?
|
| Atrial Fibrillation | 6 | 2024 | 361 | 2.030 |
Why?
|
| Retrospective Studies | 34 | 2024 | 9333 | 1.970 |
Why?
|
| Humans | 113 | 2025 | 90665 | 1.920 |
Why?
|
| Aortic Valve Stenosis | 5 | 2024 | 149 | 1.800 |
Why?
|
| Vascular Patency | 9 | 2023 | 131 | 1.710 |
Why?
|
| Aged | 43 | 2024 | 19427 | 1.700 |
Why?
|
| Anastomosis, Surgical | 8 | 2024 | 277 | 1.680 |
Why?
|
| Coronary Angiography | 10 | 2024 | 246 | 1.560 |
Why?
|
| Male | 54 | 2024 | 42987 | 1.390 |
Why?
|
| Aorta | 3 | 2023 | 291 | 1.380 |
Why?
|
| Middle Aged | 43 | 2024 | 26355 | 1.380 |
Why?
|
| Heart Neoplasms | 3 | 2019 | 64 | 1.380 |
Why?
|
| Female | 47 | 2024 | 46909 | 1.200 |
Why?
|
| Heart Valve Diseases | 4 | 2025 | 117 | 1.190 |
Why?
|
| Myocardial Bridging | 2 | 2024 | 5 | 1.120 |
Why?
|
| Pericardiectomy | 4 | 2020 | 9 | 1.120 |
Why?
|
| Bioprosthesis | 2 | 2024 | 39 | 1.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2023 | 43 | 1.000 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 242 | 0.950 |
Why?
|
| beta-Lactam Resistance | 2 | 2016 | 11 | 0.930 |
Why?
|
| Myocardial Revascularization | 3 | 2021 | 30 | 0.930 |
Why?
|
| Carbapenems | 2 | 2016 | 12 | 0.930 |
Why?
|
| Acinetobacter Infections | 2 | 2016 | 18 | 0.930 |
Why?
|
| Length of Stay | 10 | 2020 | 757 | 0.920 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 385 | 0.920 |
Why?
|
| Cryosurgery | 1 | 2024 | 59 | 0.920 |
Why?
|
| Thoracic Wall | 1 | 2024 | 24 | 0.910 |
Why?
|
| Iliac Artery | 1 | 2024 | 41 | 0.900 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 48 | 0.890 |
Why?
|
| Balloon Occlusion | 1 | 2023 | 30 | 0.840 |
Why?
|
| Operative Time | 5 | 2024 | 150 | 0.830 |
Why?
|
| Fibroma | 2 | 2019 | 33 | 0.790 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 183 | 0.770 |
Why?
|
| Reoperation | 3 | 2019 | 610 | 0.770 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 93 | 0.760 |
Why?
|
| One-Lung Ventilation | 2 | 2020 | 4 | 0.760 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2024 | 160 | 0.750 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 6816 | 0.740 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 3 | 0.710 |
Why?
|
| Cross Infection | 2 | 2012 | 151 | 0.710 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 60 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 805 | 0.680 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 70 | 0.680 |
Why?
|
| Mortality | 2 | 2018 | 148 | 0.670 |
Why?
|
| Analgesia | 2 | 2021 | 58 | 0.670 |
Why?
|
| Pericarditis | 1 | 2019 | 15 | 0.660 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.650 |
Why?
|
| Physician Assistants | 1 | 2019 | 21 | 0.650 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 38 | 0.640 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 320 | 0.640 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 98 | 0.640 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 117 | 0.620 |
Why?
|
| Heart Valve Prosthesis | 4 | 2025 | 100 | 0.620 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 117 | 0.610 |
Why?
|
| Blood Transfusion | 1 | 2019 | 170 | 0.610 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 99 | 0.600 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 3697 | 0.600 |
Why?
|
| Tertiary Care Centers | 3 | 2016 | 112 | 0.600 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 136 | 0.590 |
Why?
|
| Equipment Design | 6 | 2024 | 423 | 0.570 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.550 |
Why?
|
| Suture Techniques | 1 | 2018 | 144 | 0.550 |
Why?
|
| Stroke | 2 | 2023 | 1004 | 0.530 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 28 | 0.530 |
Why?
|
| Heart Ventricles | 2 | 2019 | 792 | 0.520 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 299 | 0.520 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2018 | 245 | 0.520 |
Why?
|
| Adult | 15 | 2024 | 26958 | 0.520 |
Why?
|
| beta-Lactamases | 1 | 2016 | 56 | 0.510 |
Why?
|
| Postoperative Complications | 5 | 2018 | 2344 | 0.510 |
Why?
|
| Hemorrhage | 1 | 2018 | 290 | 0.510 |
Why?
|
| Catheter Ablation | 2 | 2016 | 257 | 0.500 |
Why?
|
| Bupivacaine | 1 | 2015 | 45 | 0.500 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2022 | 58 | 0.500 |
Why?
|
| Laparoscopy | 1 | 2022 | 782 | 0.490 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 77 | 0.480 |
Why?
|
| Heart Diseases | 1 | 2017 | 306 | 0.480 |
Why?
|
| Feasibility Studies | 3 | 2024 | 791 | 0.460 |
Why?
|
| Risk Factors | 9 | 2025 | 5581 | 0.450 |
Why?
|
| Pain Management | 1 | 2015 | 144 | 0.450 |
Why?
|
| Sternotomy | 2 | 2023 | 24 | 0.430 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2025 | 204 | 0.420 |
Why?
|
| Sternum | 2 | 2023 | 35 | 0.420 |
Why?
|
| Heart Arrest, Induced | 2 | 2022 | 29 | 0.410 |
Why?
|
| Acinetobacter | 1 | 2012 | 4 | 0.400 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 30 | 0.380 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 39 | 0.380 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 156 | 0.360 |
Why?
|
| Heart | 3 | 2023 | 580 | 0.340 |
Why?
|
| Coronary Disease | 1 | 2011 | 261 | 0.340 |
Why?
|
| Saudi Arabia | 3 | 2016 | 16 | 0.340 |
Why?
|
| Tricuspid Valve | 2 | 2020 | 101 | 0.330 |
Why?
|
| Postoperative Period | 3 | 2019 | 301 | 0.320 |
Why?
|
| Perioperative Period | 2 | 2019 | 25 | 0.320 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2020 | 74 | 0.310 |
Why?
|
| Surgeons | 3 | 2024 | 252 | 0.310 |
Why?
|
| Heart Atria | 2 | 2016 | 285 | 0.300 |
Why?
|
| Ischemia | 2 | 2024 | 254 | 0.300 |
Why?
|
| Hemodynamics | 3 | 2024 | 739 | 0.300 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 158 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 357 | 0.290 |
Why?
|
| Heart Failure | 1 | 2018 | 1270 | 0.290 |
Why?
|
| Pericardium | 2 | 2019 | 70 | 0.290 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2018 | 62 | 0.290 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 201 | 0.280 |
Why?
|
| Prosthesis Design | 2 | 2019 | 307 | 0.280 |
Why?
|
| Stroke Volume | 2 | 2022 | 482 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 697 | 0.270 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2017 | 521 | 0.270 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 618 | 0.260 |
Why?
|
| Consensus | 2 | 2025 | 372 | 0.250 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.250 |
Why?
|
| Heart Transplantation | 2 | 2023 | 744 | 0.240 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 1709 | 0.240 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2019 | 100 | 0.230 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 451 | 0.230 |
Why?
|
| Endoscopes | 1 | 2004 | 9 | 0.230 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 151 | 0.220 |
Why?
|
| Femoral Artery | 1 | 2024 | 84 | 0.220 |
Why?
|
| Microwaves | 1 | 2004 | 36 | 0.220 |
Why?
|
| Simulation Training | 2 | 2024 | 101 | 0.220 |
Why?
|
| Time Factors | 4 | 2025 | 5365 | 0.220 |
Why?
|
| Catheterization, Peripheral | 1 | 2024 | 60 | 0.220 |
Why?
|
| Quality Indicators, Health Care | 1 | 2025 | 149 | 0.220 |
Why?
|
| Clinical Competence | 3 | 2024 | 796 | 0.220 |
Why?
|
| Constriction | 1 | 2023 | 27 | 0.210 |
Why?
|
| Hospital Mortality | 2 | 2019 | 426 | 0.210 |
Why?
|
| Cluster Analysis | 2 | 2016 | 372 | 0.210 |
Why?
|
| Internship and Residency | 2 | 2023 | 1068 | 0.210 |
Why?
|
| Patient Positioning | 2 | 2020 | 65 | 0.210 |
Why?
|
| Catheterization | 1 | 2024 | 239 | 0.200 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 727 | 0.200 |
Why?
|
| Thoracotomy | 1 | 2022 | 64 | 0.200 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2024 | 79 | 0.190 |
Why?
|
| Prognosis | 2 | 2019 | 3814 | 0.180 |
Why?
|
| Colombia | 1 | 2020 | 17 | 0.180 |
Why?
|
| Survival Analysis | 2 | 2017 | 1500 | 0.180 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 50 | 0.180 |
Why?
|
| Morphine | 1 | 2021 | 130 | 0.180 |
Why?
|
| Lead Poisoning | 1 | 2020 | 12 | 0.170 |
Why?
|
| Nobel Prize | 1 | 2020 | 10 | 0.170 |
Why?
|
| Prevalence | 3 | 2023 | 1251 | 0.170 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 24 | 0.170 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 64 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2023 | 328 | 0.170 |
Why?
|
| Career Choice | 1 | 2021 | 149 | 0.170 |
Why?
|
| Epicardial Mapping | 1 | 2019 | 10 | 0.170 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 19 | 0.170 |
Why?
|
| Pain | 1 | 2022 | 399 | 0.170 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 60 | 0.170 |
Why?
|
| Genotype | 2 | 2016 | 1855 | 0.160 |
Why?
|
| Inservice Training | 1 | 2019 | 38 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2020 | 185 | 0.160 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 7 | 0.160 |
Why?
|
| Young Adult | 3 | 2017 | 6431 | 0.160 |
Why?
|
| Safety | 1 | 2019 | 144 | 0.160 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2019 | 67 | 0.160 |
Why?
|
| History, 20th Century | 1 | 2020 | 315 | 0.160 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 429 | 0.150 |
Why?
|
| Interactive Ventilatory Support | 1 | 2018 | 5 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2019 | 51 | 0.150 |
Why?
|
| Surgical Staplers | 1 | 2018 | 11 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 198 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2019 | 305 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 16 | 0.150 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 146 | 0.150 |
Why?
|
| Radial Artery | 1 | 2017 | 33 | 0.140 |
Why?
|
| Gender Identity | 1 | 2018 | 55 | 0.140 |
Why?
|
| Saphenous Vein | 1 | 2017 | 62 | 0.140 |
Why?
|
| Morbidity | 1 | 2018 | 151 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 97 | 0.140 |
Why?
|
| Acute Disease | 1 | 2019 | 854 | 0.140 |
Why?
|
| Child, Preschool | 2 | 2016 | 3773 | 0.140 |
Why?
|
| Risk | 1 | 2018 | 656 | 0.140 |
Why?
|
| Echocardiography | 2 | 2019 | 947 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2018 | 4349 | 0.140 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 13 | 0.140 |
Why?
|
| Overweight | 1 | 2017 | 118 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1883 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 270 | 0.130 |
Why?
|
| Atrial Septum | 1 | 2016 | 9 | 0.130 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 54 | 0.130 |
Why?
|
| Pericarditis, Constrictive | 1 | 2016 | 5 | 0.130 |
Why?
|
| Coronary Sinus | 1 | 2016 | 10 | 0.130 |
Why?
|
| Recurrence | 1 | 2019 | 1164 | 0.130 |
Why?
|
| Ventricular Fibrillation | 1 | 2016 | 69 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2020 | 459 | 0.130 |
Why?
|
| Plasmids | 1 | 2016 | 292 | 0.130 |
Why?
|
| Heart Conduction System | 1 | 2016 | 117 | 0.130 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 103 | 0.130 |
Why?
|
| Liposomes | 1 | 2015 | 93 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 30 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 245 | 0.120 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 124 | 0.120 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 31 | 0.120 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 96 | 0.120 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 67 | 0.120 |
Why?
|
| Therapeutics | 1 | 2014 | 12 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2705 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 116 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 185 | 0.120 |
Why?
|
| Delphi Technique | 2 | 2025 | 105 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2018 | 778 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 367 | 0.120 |
Why?
|
| Device Removal | 1 | 2016 | 169 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 923 | 0.110 |
Why?
|
| Organ Preservation | 1 | 1995 | 120 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 956 | 0.110 |
Why?
|
| Hypertension | 1 | 2019 | 749 | 0.110 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 39 | 0.110 |
Why?
|
| Quality of Life | 1 | 2021 | 1694 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 324 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1873 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 872 | 0.100 |
Why?
|
| Child | 2 | 2016 | 7225 | 0.100 |
Why?
|
| Software | 1 | 2017 | 669 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2016 | 281 | 0.100 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 20 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2012 | 17 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 52 | 0.100 |
Why?
|
| Wisconsin | 1 | 2011 | 43 | 0.100 |
Why?
|
| Adolescent | 2 | 2016 | 9358 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2012 | 2890 | 0.090 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 109 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 823 | 0.090 |
Why?
|
| Electrocardiography | 3 | 2019 | 498 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 979 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2782 | 0.090 |
Why?
|
| Infection Control | 1 | 2012 | 124 | 0.090 |
Why?
|
| Algorithms | 2 | 2017 | 1919 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2012 | 680 | 0.090 |
Why?
|
| Burns | 1 | 2012 | 144 | 0.090 |
Why?
|
| Survival Rate | 2 | 2011 | 1893 | 0.080 |
Why?
|
| Angiography | 1 | 2009 | 208 | 0.080 |
Why?
|
| Lung | 1 | 1995 | 1304 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2012 | 399 | 0.080 |
Why?
|
| Image Enhancement | 3 | 2017 | 566 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 165 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2021 | 2338 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 2019 | 0.070 |
Why?
|
| Hospitalization | 1 | 2012 | 899 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 3193 | 0.060 |
Why?
|
| Disease Progression | 1 | 2009 | 1487 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2025 | 92 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2024 | 92 | 0.060 |
Why?
|
| Cattle | 1 | 2024 | 379 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 91 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 593 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 126 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 184 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2025 | 214 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2024 | 171 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2022 | 39 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2021 | 45 | 0.050 |
Why?
|
| Decontamination | 1 | 2021 | 9 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 252 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2025 | 878 | 0.050 |
Why?
|
| Weights and Measures | 1 | 2020 | 7 | 0.040 |
Why?
|
| Contraindications | 1 | 2020 | 70 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 181 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 511 | 0.040 |
Why?
|
| United States | 2 | 2023 | 7147 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 309 | 0.040 |
Why?
|
| Myocardium | 1 | 2022 | 574 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 406 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 185 | 0.040 |
Why?
|
| Animals | 3 | 2024 | 27720 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 6 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1727 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 17 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 574 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1073 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 682 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 150 | 0.030 |
Why?
|
| Heart Injuries | 1 | 2016 | 20 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 602 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1996 | 145 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 959 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1996 | 135 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Raffinose | 1 | 1995 | 23 | 0.030 |
Why?
|
| Partial Pressure | 1 | 1995 | 50 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 205 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 59 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 789 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1747 | 0.030 |
Why?
|
| Reperfusion | 1 | 1995 | 32 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 105 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 78 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1995 | 103 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 108 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 340 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 111 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 465 | 0.030 |
Why?
|
| Rabbits | 1 | 1995 | 641 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 615 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 852 | 0.030 |
Why?
|
| Adenosine | 1 | 1995 | 245 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 809 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1995 | 906 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 400 | 0.020 |
Why?
|
| Oxygen | 1 | 1995 | 747 | 0.020 |
Why?
|
| Insulin | 1 | 1995 | 1162 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 85 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 1996 | 117 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1996 | 982 | 0.010 |
Why?
|